These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 17380217)

  • 21. The impact of diabetes on cognition: what can be learned from rodent models?
    Biessels GJ; Gispen WH
    Neurobiol Aging; 2005 Dec; 26 Suppl 1():36-41. PubMed ID: 16223548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive impairment correlates to low auditory event-related potential amplitudes in type 1 diabetes.
    Cooray GK; Maurex L; Brismar T
    Psychoneuroendocrinology; 2008 Aug; 33(7):942-50. PubMed ID: 18650025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Depression and frontal dysfunction: risks for the elderly?].
    Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
    Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of cognitive impairment in type 1 diabetes.
    Brismar T; Maurex L; Cooray G; Juntti-Berggren L; Lindström P; Ekberg K; Adner N; Andersson S
    Psychoneuroendocrinology; 2007; 32(8-10):1041-51. PubMed ID: 17884300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thailand diabetes registry (TDR) project: clinical status and long term vascular complications in diabetic patients.
    Rawdaree P; Ngarmukos C; Deerochanawong C; Suwanwalaikorn S; Chetthakul T; Krittiyawong S; Benjasuratwong Y; Bunnag P; Kosachunhanun N; Plengvidhya N; Leelawatana R; Prathipanawatr T; Likitmaskul S; Mongkolsomlit S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S1-9. PubMed ID: 17717877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No evidence for increased self-reported cognitive failure in Type 1 and Type 2 diabetes: a cross-sectional study.
    Wessels AM; Pouwer F; Geelhoed-Duijvestijn PH; Snel M; Kostense PJ; Scheltens P; Heine RJ; Snoek FJ
    Diabet Med; 2007 Jul; 24(7):735-40. PubMed ID: 17403117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
    Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
    Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular risk factors and Alzheimer's disease.
    Cechetto DF; Hachinski V; Whitehead SN
    Expert Rev Neurother; 2008 May; 8(5):743-50. PubMed ID: 18457531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular factors in geriatric psychiatry: time to take a serious look.
    Flicker L
    Curr Opin Psychiatry; 2008 Nov; 21(6):551-4. PubMed ID: 18852561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metabolic syndrome is associated with decelerated cognitive decline in the oldest old.
    van den Berg E; Biessels GJ; de Craen AJ; Gussekloo J; Westendorp RG
    Neurology; 2007 Sep; 69(10):979-85. PubMed ID: 17785666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lifestyle-related factors in predementia and dementia syndromes.
    Solfrizzi V; Capurso C; D'Introno A; Colacicco AM; Santamato A; Ranieri M; Fiore P; Capurso A; Panza F
    Expert Rev Neurother; 2008 Jan; 8(1):133-58. PubMed ID: 18088206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey.
    Kjeldsen SE; Naditch-Brule L; Perlini S; Zidek W; Farsang C
    J Hypertens; 2008 Oct; 26(10):2064-70. PubMed ID: 18806632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma fibrinogen is associated with cognitive decline and risk for dementia in patients with mild cognitive impairment.
    Xu G; Zhang H; Zhang S; Fan X; Liu X
    Int J Clin Pract; 2008 Jul; 62(7):1070-5. PubMed ID: 17916180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline?
    Kawamura T; Umemura T; Hotta N
    J Diabetes Investig; 2012 Oct; 3(5):413-23. PubMed ID: 24843599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factors.
    Feinkohl I; Price JF; Strachan MW; Frier BM
    Alzheimers Res Ther; 2015; 7(1):46. PubMed ID: 26060511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential mechanisms underlying the associations between liver enzymes and risk for type 2 diabetes.
    Venkatesan C; Younossi ZM
    Hepatology; 2012 Mar; 55(3):968-70. PubMed ID: 22362600
    [No Abstract]   [Full Text] [Related]  

  • 37. A New View of Diabetes.
    Eccles RG
    Hospital (Lond 1886); 1908 Jul; 44(1141):374-375. PubMed ID: 29819067
    [No Abstract]   [Full Text] [Related]  

  • 38. Micro-structural white matter abnormalities in type 2 diabetic patients: a DTI study using TBSS analysis.
    Tan X; Fang P; An J; Lin H; Liang Y; Shen W; Leng X; Zhang C; Zheng Y; Qiu S
    Neuroradiology; 2016 Dec; 58(12):1209-1216. PubMed ID: 27783100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type 2 diabetes, cognitive function and dementia: vascular and metabolic determinants.
    van den Berg E; Kessels RP; Kappelle LJ; de Haan EH; Biessels GJ;
    Timely Top Med Cardiovasc Dis; 2007 Feb; 11():E7. PubMed ID: 17380217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type 2 diabetes, cognitive function and dementia: vascular and metabolic determinants.
    van den Berg E; Kessels RP; Kappelle LJ; de Haan EH; Biessels GJ;
    Drugs Today (Barc); 2006 Nov; 42(11):741-54. PubMed ID: 17171193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.